pharma · Epidermolysis Bullosa Simplex · INM
InMed Pharmaceuticals
InMed Pharmaceuticals patent portfolio — 15 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- Vancouver, CA
- Employees
- 19
- Programs
- 1
- Drugs
- 0
- Patents
- 15
InMed Pharmaceuticals patents
15 pharmaceutical patents indexed for InMed Pharmaceuticals. 3 expire within 24 months.
InMed Pharmaceuticals has 15 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 3 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 12357604
Topical formulations of cannabinoids and use thereof in the treatment of pain
granted -
US 12083229
Ocular drug delivery formulation
granted -
US 12042479
Use of topical formulations of cannabinoids in the treatment of epidermolysis bullosa and related connective tissue disorders
granted -
US 11472840
Acetylcholine receptor-binding peptide
granted -
US 11471534
Chitosan-pluronic complex and nano-carrier comprising same
granted -
US 8361485
Conditioned cell culture medium compositions and methods of use
granted -
US 8268336
Compositions containing aromatic aldehydes and their use in treatments
granted -
US 8246969
Compositions containing aromatic aldehydes and their use in treatments
granted -
US 8246971
Compositions containing aromatic aldehydes and their use in treatment
granted -
US 8236288
Melanin modification compositions and methods of use
granted -
US 8138147
Conditioned cell culture medium compositions and methods of use
granted -
US 7374770
Topical composition for follicular delivery of an ornithine decarboxylase inhibitor
granted -
US 7160726
Compositions comprising conditioned cell culture media and uses thereof
granted -
US 7118746
Conditioned cell culture medium compositions and methods of use
granted -
US 6896909
Formulations containing iron ores for the topical treatment of bioenergetic and electromagnetic disorders
expired
Frequently asked questions
How many patents does InMed Pharmaceuticals have?
15 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do InMed Pharmaceuticals patents expire?
3 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.